Concepedia

Mingguang Mo

MM

Statistics

Publications

10

Citations

238

H-Index

10

Active since

2013

Affiliations

Fudan University(Current)

Chinese Academy of Sciences

SUNY Downstate Health Sciences University

Shanghai Institute of Materia Medica

Shanghai Jiao Tong University

Mingguang Mo is an author at Fudan University specializing in pharmacy, drug discovery, and pharmacology.

ORCID

Publications per year

2013–2020

10

Publications

10

Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer

Yan Deng, Jia-chun Hu, Shuhua He et al. · Acta Pharmacologica Sinica · 2020 · 49 citations · Full text

, , +17

Discovery of a Novel Series of Imidazo[1,2-<i>a</i>]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A<sub>2</sub> Inhibitors

Xinde Chen, Wenwei Xu, Kai Wang et al. · Journal of Medicinal Chemistry · 2015 · 42 citations · Full text

, , +11

Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor

Yali Li, Taomin Huang, Bin Lou et al. · European Journal of Medicinal Chemistry · 2018 · 31 citations · Full text

, , +12

Discovery of 4-Benzyloxybenzo[<i>d</i>]isoxazole-3-amine Derivatives as Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors that Reduce Chronic Inflammation in <i>db</i>/<i>db</i> Mice

Mingguang Mo, Jintong Yang, Xian‐Cheng Jiang et al. · Journal of Medicinal Chemistry · 2018 · 26 citations · Full text

, , +10

Site-Selective Phosphoglycerate Mutase 1 Acetylation by a Small Molecule

Xiaodan Zhang, Lulu Jiang, Ke Huang et al. · ACS Chemical Biology · 2020 · 20 citations

, , +13

1–5 of 10